Increased Cancer Risk in Patients with Endogenous Cushing Syndrome
Overview
A nationwide cohort study in Taiwan found that patients with endogenous Cushing syndrome (CS) have a significantly higher incidence of cancer compared to the general population. The standardized incidence ratio (SIR) for cancer in CS patients was 2.08, with liver, kidney, and lung cancers being the most common types observed.
Background
Cushing syndrome is characterized by prolonged exposure to elevated glucocorticoids and is associated with metabolic complications such as obesity and diabetes, both known cancer risk factors. Previous epidemiological studies on CS have been limited and mostly focused on Western populations, with no prior large-scale data from Asian cohorts. Given the metabolic derangements in CS, this study aimed to clarify whether endogenous CS independently increases cancer risk using comprehensive national health data from Taiwan.
The incidence of endogenous CS in Taiwan decreased from 4.84 to 3.77 per million person-years between 2006 and 2017.
Patients with endogenous CS have a more than twofold increased risk of developing cancer compared to the general population (SIR 2.08).
Liver, kidney, and lung cancers were the most frequently observed malignancies among CS patients.
Majority of CS patients were female (80%) with a mean age of 45 years at diagnosis.
CS subtypes included 35.4% pituitary origin (Cushing disease) and 64.6% adrenal origin.
Clinical Implications
Clinicians should be aware of the elevated cancer risk in patients with endogenous Cushing syndrome, particularly for liver, kidney, and lung cancers. Regular cancer surveillance and risk factor management, including control of metabolic complications, may be warranted in this population to improve long-term outcomes.
Conclusion
This large-scale cohort study demonstrates that endogenous Cushing syndrome is associated with a significantly increased incidence of cancer. These findings highlight the need for heightened clinical vigilance and tailored cancer screening strategies in patients with CS.
References
Taiwan National Health Insurance Data Study 2006-2017 -- Increased Cancer Risk Linked to Cushing Syndrome
